Arcellx Inc
NASDAQ:ACLX
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
50.91
106.53
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one ACLX stock under the Base Case scenario is 56.42 USD. Compared to the current market price of 68.86 USD, Arcellx Inc is Overvalued by 18%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Arcellx Inc
Loading...
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
|
US |
E
|
Epizyme Inc
F:EPE
|
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
|
US |
S
|
Seagen Inc
F:SGT
|
|
US |
![]() |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:

Revenue & Expenses Breakdown
Arcellx Inc
Balance Sheet Decomposition
Arcellx Inc
Current Assets | 554.2m |
Cash & Short-Term Investments | 543.3m |
Other Current Assets | 10.9m |
Non-Current Assets | 93.9m |
Long-Term Investments | 21.9m |
PP&E | 69.2m |
Other Non-Current Assets | 2.8m |
Current Liabilities | 112.5m |
Accounts Payable | 4.4m |
Accrued Liabilities | 50.7m |
Other Current Liabilities | 57.4m |
Non-Current Liabilities | 118.7m |
Other Non-Current Liabilities | 118.7m |
Free Cash Flow Analysis
Arcellx Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Arcellx Inc
Revenue
|
76.8m
USD
|
Operating Expenses
|
-267.5m
USD
|
Operating Income
|
-190.7m
USD
|
Other Expenses
|
28.2m
USD
|
Net Income
|
-162.4m
USD
|
ACLX Profitability Score
Profitability Due Diligence
Arcellx Inc's profitability score is 20/100. The higher the profitability score, the more profitable the company is.
Score
Arcellx Inc's profitability score is 20/100. The higher the profitability score, the more profitable the company is.
ACLX Solvency Score
Solvency Due Diligence
Arcellx Inc's solvency score is 78/100. The higher the solvency score, the more solvent the company is.
Score
Arcellx Inc's solvency score is 78/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ACLX Price Targets Summary
Arcellx Inc
According to Wall Street analysts, the average 1-year price target for ACLX is 113.67 USD with a low forecast of 93.93 USD and a high forecast of 140.7 USD.
Dividends
Current shareholder yield for ACLX is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one ACLX stock under the Base Case scenario is 56.42 USD.
Compared to the current market price of 68.86 USD, Arcellx Inc is Overvalued by 18%.